Supplementary Material from Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Figures and Tables Supplemental Figure 1. GWAS and Quality Control Pipeline. Abbreviations: IBD: identity by descent; SD: standard deviation; MAF: minor allele frequency. Supplemental Table 1. Additional Clinical and Sociodemographic Characteristics for 1,010 Testicular Cancer Survivors According to Residual Platinum Values. Supplemental Table 2. Univariate Multinomial Regression of the Association Between Residual Platinum Values and Clinical Phenotypes Relevant to Cisplatin-Based Chemotherapy. Supplemental Table 3. Multinomial Regression of the Association Between Residual Platinum Values and Phenotypes Relevant to Cisplatin-Based Chemotherapy with Age at Diagnosis as a Covariate. Supplemental Table 4. GWAS Results (P < 0.0001).
Authors: Matthew R. Trendowski, Omar El-Charif, Mark J. Ratain, Patrick Monahan, Zepeng Mu, Heather E. Wheeler, Paul C. Dinh, Darren R. Feldman, Shirin Ardeshir-Rouhani-Fard, Robert J. Hamilton, David J. Vaughn, Chunkit Fung, Christian Kollmannsberger, Taisei Mushiroda, Michiaki Kubo, Robyn Hannigan, Frederick Strathmann, Lawrence H. Einhorn, Sophie D. Fossa, Lois B. Travis, M. Eileen Dolan
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361936748